 |
|
|
|
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
|
|
 |
|
|
The FDA announced the 1997 withdrawal of Fenfluramine and Dexfenfluramine, also called “Phen-Fen” when used together. The FDA cited findings from doctors who have evaluated patients taking these two drugs with echocardiograms, devices that pick up echoes of the sound waves as they bounce off the heart. Approximately 30 percent of patients who were evaluated had abnormal echocardiograms, indicating significant risk associated with the drugs.
Dexfenfluramine, manufactured for Interneuron Pharmaceuticals, is marketed under the name of Redux. Fenfluramine, manufactured by American Home Products Corp., is marketed under the brand name Pondimin. The drugs were used clinically for the management of obesity, but women who took the drugs as diet aids off-label have also reported side effects. The FDA still receives reports of cardiac valvular disease in persons who have used Phen-Fen.
If you have suffered any heart problems and have used Phen-Fen, Fenfluramine or Dexfenfluramine, please obtain a Free Consultation by submitting our online form, or by calling 1-800-543-9859.
Here are some other perscription drugs that have recently been recalled or have been linked to illnesses in users:
|
|
 |
|
|
|
|
|
| __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
Don’t Hesitate to Contact Robert Peirce & Associates, P.C.
For a Free and Confidential Consultation
Robert Peirce & Associates, P.C.
2500 Gulf Tower, 707 Grant Street, Pittsburgh, PA 15219
P: 1-800-543-9859 F: 412-281-4229 |
| |
| Potential clients: Please be advised that submitting the "free consultation" form through our online system does not commit you to hiring our firm, and does not mean that you have retained an attorney for your potential case. The inquiry form will be reviewed by an attorney, and someone from Robert Peirce & Associates, P.C. will contact you to discuss the facts of your potential case. No attorney-client relationship is formed until a fee agreement is signed. We cannot guarantee the security of this site, and are not responsible for storing sensitive information. |
|
|
